Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
pemetrexed plus carboplatin
DRUG
2 trials
Sponsors
Gruppo Oncologico Italiano di Ricerca Clinica
, Baohui Han
Conditions
Advanced Non-Small Cell Lung Cancer
Non-Small-Cell Lung Cancer
Phase 2
Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC
NCT00786331
Gruppo Oncologico Italiano di Ricerca Clinica
Advanced Non-Small Cell Lung Cancer
Start: 2007-07-31
End: 2009-12-31
Target: 230
Updated: 2009-08-03
Unknown Phase
Combination of Chemotherapy and Gefitinib as First-line Treatment
Completed
NCT02148380
Baohui Han
Non-Small-Cell Lung Cancer
Start: 2014-05-31
End: 2015-12-31
Updated: 2016-04-20
Related Papers
Cost‐effectiveness analysis of first‐line treatments for advanced epidermal growth factor receptor‐mutant non‐small cell lung cancer patients
Cancer Medicine
2021-02-24
20 citations
Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for Advanced EGFR-Positive Lung Adenocarcinoma Patients: Updated Data and Exploratory In Vitro Study.
2020-04-01
17 citations
Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small-cell lung cancer: treating the right patients based on individualized treatment effect prediction.
2016-04-06
4 citations